Skip to search boxSkip to navigationSkip to main content

Allergies and Asthma: Do Atopic Disorders Result from Inadequate Immune Homeostasis arising from Infant Gut Dysbiosis?

  • Christine C. Johnson(corresponding author)
    ,
  • Dennis R. Ownby
*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Our global hypothesis is that atopic conditions and asthma develop because an individuals immune system is not able to appropriately resolve inflammation resulting from allergen exposures. We propose that the failure to appropriately down-regulate inflammation and produce a toleragenic state results primarily from less robust immune homeostatic processes rather than from a tendency to over-respond to allergenic stimuli. An individual with lower immune homeostatic capacity is unable to rapidly and completely terminate, on average over time, immune responses to innocuous allergens, increasing risk of allergic disease. A lack of robust homeostasis also increases the risk of other inflammatory conditions, such as prolonged respiratory viral infections and obesity, leading to the common co-occurrence of these conditions. Further, we posit that the development of vigorous immune homeostatic mechanisms is an evolutionary adaptation strongly influenced by both 1) exposure to a diverse maternal microbiota through the prenatal period, labor and delivery, and, 2) an orderly assemblage process of the infants gut microbiota ecosystem shaped by breastfeeding and early exposure to a wide variety of ingested foods and environmental microbes. This early succession of microbial communities together with early allergen exposures orchestrate the development of an immune system with a robust ability to optimally control inflammatory responses and a lowered risk for atopic disorders.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 379-388 (10 pages)

Journal (Volume, Issue Number)

Expert Review of Clinical Immunology (Volume 12, Issue 4)

Publication milestones

  • Accepted/In press - 02/05/2016
  • Published - 04/02/2016

Publication status

Published - 04/02/2016

ISSN

1744-666X

Publication IDs

  • Scopus: 84958057229
  • PubMed: 26776722

Publication metrics

Metrics

SciVal
citations
28
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
SciVal
FWCI
0.81
SciVal
Author count
2
SciVal
Paper percentile
90
SciVal
Top percentile
10
Scopus
citations

PlumX, opens in new tab

Mentions
3
Captures
134
Social media
7
Citation count
43

Funding Details

Financial and competing interests disclosure: This work was funded by the National Institutes of Health, USA (P01 AI089473). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
FundersFunding number
NIH
-
NIAID
P01AI089473